Exelixis Inc (EXEL)
23.87
+0.26
(+1.10%)
USD |
NASDAQ |
Mar 27, 16:00
23.86
0.00 (0.00%)
After-Hours: 20:00
Exelixis Shareholders Equity (Quarterly): 2.264B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.264B |
September 30, 2023 | 2.348B |
June 30, 2023 | 2.528B |
March 31, 2023 | 2.555B |
December 31, 2022 | 2.488B |
September 30, 2022 | 2.491B |
June 30, 2022 | 2.391B |
March 31, 2022 | 2.294B |
December 31, 2021 | 2.211B |
September 30, 2021 | 2.112B |
June 30, 2021 | 2.043B |
March 31, 2021 | 1.911B |
December 31, 2020 | 1.879B |
September 30, 2020 | 1.852B |
June 30, 2020 | 1.833B |
March 31, 2020 | 1.748B |
December 31, 2019 | 1.686B |
September 30, 2019 | 1.604B |
June 30, 2019 | 1.489B |
March 31, 2019 | 1.385B |
December 31, 2018 | 1.287B |
September 30, 2018 | 915.97M |
June 30, 2018 | 774.97M |
March 31, 2018 | 669.77M |
December 31, 2017 | 284.96M |
Date | Value |
---|---|
September 30, 2017 | 238.72M |
June 30, 2017 | 148.51M |
March 31, 2017 | 119.75M |
December 31, 2016 | 89.32M |
September 30, 2016 | 32.02M |
June 30, 2016 | -186.13M |
March 31, 2016 | -155.95M |
December 31, 2015 | -140.81M |
September 30, 2015 | -74.23M |
June 30, 2015 | -188.19M |
March 31, 2015 | -146.76M |
December 31, 2014 | -114.83M |
September 30, 2014 | -58.51M |
June 30, 2014 | 3.243M |
March 31, 2014 | 71.48M |
December 31, 2013 | 66.24M |
September 30, 2013 | 132.76M |
June 30, 2013 | 196.33M |
March 31, 2013 | 254.85M |
December 31, 2012 | 296.43M |
September 30, 2012 | 340.84M |
June 30, 2012 | 99.05M |
March 31, 2012 | 132.35M |
December 31, 2011 | 90.63M |
September 30, 2011 | 3.054M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.385B
Minimum
Mar 2019
2.555B
Maximum
Mar 2023
2.056B
Average
2.078B
Median
Shareholders Equity (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 25.97B |
Bristol-Myers Squibb Co | 29.43B |
Johnson & Johnson | 68.77B |
Merck & Co Inc | 37.58B |
Pfizer Inc | 89.01B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.942B |
Total Liabilities (Quarterly) | 678.44M |
Current Ratio | 3.343 |